We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
-4.82%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.19B
AUM Growth
+$65.2M
Cap. Flow
+$156M
Cap. Flow %
13.1%
Top 10 Hldgs %
5.3%
Holding
1,418
New
379
Increased
331
Reduced
358
Closed
311

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$10.5M
2
MMM icon
3M
MMM
+$6.83M
3
GILD icon
Gilead Sciences
GILD
+$6.68M
4
ROKU icon
Roku
ROKU
+$6.41M
5
DOCU
DocuSign
DOCU
+$6.09M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$5.8M
2
MRVL icon
Marvell Technology
MRVL
+$5.73M
3
VRNS icon
Varonis Systems
VRNS
+$5.65M
4
SLB icon
SLB Ltd
SLB
+$5.57M
5
CHGG icon
Chegg
CHGG
+$5.43M

Sector Composition

Rank Sector Weight
1 Technology 20.62%
2 Industrials 13.7%
3 Healthcare 13.14%
4 Consumer Discretionary 12.77%
5 Financials 11.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIA
1026
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$90K 0.01%
2,180
-95
-4% -$5.04K
OPFI icon
1027
OppFi
OPFI
$836M
$89K 0.01%
26,068
-3,683
-12% -$15.6K
PLSE icon
1028
Pulse Biosciences
PLSE
$2.64B
$89K 0.01%
+18,402
New +$151K
PVL
1029
Permianville Royalty Trust
PVL
$56.8M
$89K 0.01%
+35,597
New +$85.7K
EVLO
1030
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$89K 0.01%
+1,311
New +$109K
SRAX
1031
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$89K 0.01%
81,383
-1,417
-2% -$6.71K
HOOK
1032
DELISTED
HOOKIPA Pharma
HOOK
$88K 0.01%
3,860
+308
+9% +$5.52K
PLRX icon
1033
Pliant Therapeutics
PLRX
$65M
$87K 0.01%
+12,473
New +$127K
PHX
1034
DELISTED
PHX Minerals
PHX
$86K 0.01%
28,130
+2,318
+9% +$5.91K
DCH
1035
Dauch Corp
DCH
$1.42B
$84K 0.01%
+10,789
New +$92K
ACHV icon
1036
Achieve Life Sciences
ACHV
$684M
$83K 0.01%
11,001
– –
ASRT
1037
DELISTED
Assertio
ASRT
$83K 0.01%
+1,927
New +$71.9K
CDZI icon
1038
Cadiz
CDZI
$273M
$82K 0.01%
39,516
-39,247
-50% -$98.9K
RFL icon
1039
Rafael Holdings
RFL
$106M
$82K 0.01%
33,032
+9,517
+40% +$32.6K
HMLP
1040
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$82K 0.01%
11,169
-35,609
-76% -$166K
BYSI icon
1041
BeyondSpring
BYSI
$40.1M
$78K 0.01%
+35,591
New +$103K
DSP icon
1042
Viant Technology
DSP
$246M
$78K 0.01%
11,843
-9,835
-45% -$75K
ALGS icon
1043
Aligos Therapeutics
ALGS
$29.3M
$76K 0.01%
+1,423
New +$114K
RAIL icon
1044
FreightCar America
RAIL
$259M
$76K 0.01%
+12,805
New +$52.5K
XOS icon
1045
Xos
XOS
$40.5M
$76K 0.01%
844
-367
-30% -$27.6K
BDTX icon
1046
Black Diamond Therapeutics
BDTX
$103M
$75K 0.01%
27,123
-19,303
-42% -$70.5K
APLT
1047
DELISTED
Applied Therapeutics
APLT
$73K 0.01%
+34,372
New +$92.1K
GRTX
1048
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$72K 0.01%
+30,442
New +$79.3K
BOLT icon
1049
Bolt Biotherapeutics
BOLT
$7.59M
$71K 0.01%
+1,289
New +$86.8K
ARQ icon
1050
Arq
ARQ
$88M
$71K 0.01%
11,447
-3,575
-24% -$22.7K
40 41
42
43 44

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Occudo Quantitative Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Occudo Quantitative Strategies held 1,418 positions worth $1.19B, up 5.8% from $1.13B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Occudo Quantitative Strategies deployed $156M of net new capital in Q1 2022, opening 379 new positions and adding to 331 existing holdings. Its largest new stake was Kodiak Sciences: 267,985 shares worth $2.07M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Chegg, an estimated $5.43M trimmed.

  • Occudo Quantitative Strategies's largest Q1 2022 buy was Kodiak Sciences: 267,985 shares worth $2.07M.
  • Occudo Quantitative Strategies added most to Sherwin-Williams in Q1 2022, an estimated $6.05M increase.
  • Occudo Quantitative Strategies's biggest Q1 2022 reduction was Chegg, cutting an estimated $5.43M.
  • Occudo Quantitative Strategies fully exited Intercontinental Exchange in Q1 2022, selling an estimated $5.8M.
  • Occudo Quantitative Strategies's ten largest holdings make up 5.3% of its $1.19B portfolio in Q1 2022.
  • Occudo Quantitative Strategies opened 379 new positions and closed 311 in Q1 2022.
  • Occudo Quantitative Strategies's portfolio value rose 5.8% quarter-over-quarter to $1.19B.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.